| Patient | Robert Falcon Scott |
|---|---|
| Date of birth | 1868-06-06 |
| Identifiers | MRN HR-EX002-SYN-TD; SSN (made up) 000-02-6713 |
| Document date | 1910-05-26 |
| Author | Ottilie Harrow-Mbeki, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Pre-departure review: blood pressure on losartan, mental health, and the expedition medical plan. [S]
Mr. Scott returns about three weeks before the expedition leaves. The gastroenteritis three weeks ago settled within three days; he held losartan for two days and restarted it once he was eating normally. His home readings over the last week average 124/78 mmHg on losartan 50 mg, and he has had no lightheadedness since the illness. He has not smoked for eighteen weeks and takes varenicline. The sledging rations and the vitamin C tablets are packed. He wants to know what the medical plan is if he or another man falls ill far from the hut, and how he can look after his mind and his sleep through the polar winter and the long journeys. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Seven-day average 124/78 mmHg on losartan |
| Recent illness | Gastroenteritis resolved; losartan held for two days under the sick-day rule |
| Tobacco | No pipe for eighteen weeks |
| Mood and sleep | PHQ-9 2, GAD-7 3; sleeping six to seven hours |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or swelling |
| Neurological | Negative | No lightheadedness on standing since the illness |
| Gastrointestinal | Negative | Bowels normal; eating well |
| Psychiatric | Negative | Mood good; some worry about the timetable; sleeping well |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) | twice a day after titration | Oral route | 1910-01-13 | active | S |
| Losartan 50 mg tablet, one tablet by mouth daily; stop during vomiting, diarrhea or dehydration and restart when eating and drinking normally | once daily | Oral route | 1910-04-21 | active | S |
| Vitamin C (ascorbic acid) 250 mg tablet, one tablet by mouth daily whenever no fresh food is available, packed in every sledging ration | once daily when no fresh food is available | Oral route | 1910-05-26 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1910-05-26 | Body height | 173 | cm | S |
| 1910-05-26 | Body weight | 70.8 | kg | S |
| 1910-05-26 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1910-05-26 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1910-05-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1910-05-26 | Heart rate | 60 | /min | S |
| 1910-05-26 | Respiratory rate | 14 | /min | S |
| 1910-05-26 | Body temperature | 36.6 | Cel | S |
| 1910-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1910-05-26 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 136-145 mmol/L | Normal | S |
| 1910-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1910-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1910-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1905)/1.73 sq M | 104 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1910-05-26 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1910-05-26 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S |
Vital signs recorded on 1910-05-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 124/78, pulse 60, weight 70.8 kg, BMI 23.7 |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Mouth | Gums firm and pink |
| Extremities | Normal capillary refill in the fingers and toes; no skin damage on the feet |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at a pre-expedition medical assessment, 144/90 mmHg in the office without symptoms; hypertension not yet confirmed; one week of home readings requested | resolved | confirmed | R03.0 | S — Synthetic presenting finding at the pre-expedition assessment; no blood pressure from his lifetime is known. Superseded at the second visit by the confirmed diagnosis. |
| Nicotine dependence, pipe tobacco: about 25 g a week since his early twenties; first pipe within an hour of waking; has never tried to stop | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented tobacco use on a sledge journey; the amount and pattern are synthetic. |
| Essential hypertension, stage 1, confirmed by a one-week home blood pressure average of 138/88 mmHg; normal ECG and kidney function; low ten-year cardiovascular risk | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit; no historical measurement exists. |
| Personal history of scurvy on a long polar sledge journey in his mid-thirties, with red gums and swollen ankles and legs, treated with fresh seal meat, and full recovery; months on preserved food again ahead | active | confirmed | Z86.39 | S — Synthetic modern coding of his documented scurvy, kept on the list because the expedition will put him at risk again. |
| Acute viral gastroenteritis with mild dehydration, two weeks after starting losartan; losartan held under the sick-day rule; resolved | resolved | confirmed | A08.4 | S — Synthetic acute problem; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique, average of two readings (target below 130/80 mmHg) | Every visit | Completed today | 124/78 mmHg, at target |
| Self-management | Home blood pressure monitoring to confirm the diagnosis and guide treatment | At diagnosis and when treatment changes | Completed today | Seven-day average 124/78 mmHg on losartan |
| Examination | Weight, BMI, and cardiac auscultation | Every visit | Completed today | 70.8 kg, BMI 23.7; no murmur |
| Laboratory | Basic metabolic panel: sodium, potassium, creatinine, eGFR | Baseline; 2 to 4 weeks after starting an ARB; then every 6 months on an ARB | Completed today | Sodium 140, potassium 4.4 mmol/L, creatinine 0.94 mg/dL, eGFR 104, five weeks after starting losartan; the two-week check fell during the gastroenteritis (creatinine 1.16 mg/dL); next at about six months |
| Medication safety | Medication adherence, side effects, and sick-day rules | Every visit | Completed today | Losartan taken daily apart from two days held correctly under the sick-day rule; no lightheadedness |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Up to date | 8 mg/g at the six-week visit; next in a year |
| Laboratory | Lipid panel and HbA1c or fasting glucose | At diagnosis, then yearly | Up to date | At intake; next in a year |
| Examination | Fundoscopic examination | Yearly | Up to date | Normal at the preventive visit |
| Survey | PHQ-9 depression screen | Yearly with hypertension, and before and after a long isolated posting | Completed today | PHQ-9 2 |
| Survey | GAD-7 anxiety screen | Before and after a long isolated posting | Completed today | GAD-7 3 |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent for eighteen weeks |
| Self-management | Expedition nutrition plan: energy, weight, and vitamin C | Planned before departure, then weekly in the field | Completed today | Energy targets, weekly weights, and vitamin C 250 mg daily when no fresh food is available; supply packed |
| Self-management | Frostbite and hypothermia prevention and field treatment training | Before departure | Up to date | Course completed at the three-month visit |
| Self-management | Altitude plan for the polar plateau | Before ascent | Completed today | Gradual ascent; acetazolamide in the medical kit |
| Self-management | Mental health and sleep support plan for isolation | Before departure, then monthly in the field | Completed today | Routine, light management, monthly self-checks, and a named contact agreed |
| Self-management | Evacuation, communication, and medical kit plan | Before departure | Completed today | Written plan, communication schedule, medicine supply, and medical summary in the kit |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Circulation 2025;152(11):e114-e218) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension monograph (2026); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024); Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019); Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update (Luks AM, et al. Wilderness Environ Med 2024;35(1 Suppl):2S-19S) (2024); Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (2000); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Depression and Suicide Risk in Adults: Screening (2023); Anxiety Disorders in Adults: Screening (2023)
Follow-up: Review on his return, with blood pressure, electrolytes and creatinine, urine albumin, lipids, PHQ-9 and GAD-7. Telemedicine contact with the clinic when communication allows. [S]